Molecular dynamic investigation for ROCO-4 kinase inhibitor as treatment options for parkinsonism
The paper investigates potential inhibitors of ROCO4 kinase for Parkinson's disease treatment, identifying Mongolicain-A as a promising candidate with high specificity for the G2019S mutation.
bioRxiv · Oct 21, 2023 · PreprintNeuroscience